Quantitative determination of bilirubin and a reagent therefor

Abstract: Disclosed is a process for measuring an amount of all bilirubins in a specimen, comprising deconjugating conjugated bilirubins with a reagent comprising an enzyme capable of deconjugation to form the unconjugated bilirubin, and determining an amount of the unconjugated bilirubin in the specimen, and a reagent therefor. The present invention also provides a process for measuring an amount of the unconjugated bilirubin in a specimen, comprising oxidizing and eliminating conjugated bilirubins in the specimen with an oxidizing agent capable of oxidizing bilirubins, in the presence of a metal ion forming a complex with the bilirubins and a surfactant at pH 6.5 or less, and determining an amount of the unconjugated bilirubin in the specimen, and a reagent therefor.

Description: The present invention relates to a process for measuring the total amount of bilirubins in body fluids and a reagent therefor. Bilirubins are yellow dyes which belong to tetrapyrroles and are present as unconjugated bilirubin and conjugated bilirubins in body fluids. Conjugated bilirubins are those in which sugars (e.g. glucuronic acid) are attached to propionic acid groups of the bilirubins, while the unconjugated bilirubin is bilirubin which is not chemically modified. In case of a disease like hemolytic anemia or hemolytic jaundice, the amount of the unconjugated bilirubin increases. In case of a disease like obstructive jaundice the amount of conjugated bilirubins increase. Accordingly, the separation and quantitative determination of bilirubins is very important in clinical diagnosis. There have been proposed many methods for the separation and quantitative determination of bilirubins, such as a method using a diazo reagent, a method using high performance liquid chromatography (HPLC), a method using an oxidizing enzyme such as bilirubin oxidase and the like. The method using a diazo reagent has many variations due to the sort of the diazotization reaction accelerator and the difference of quantitative measurement of produced azobilirubins. Typical examples of the methods are a reagent of Malloy & Evelyn et al. (Journal of Biological Chemistry, Volume 119, p 481, 1937) and the like. The method using high performance liquid chromatography (HPLC) includes some variations, such as the Lauff et al. method wherein various bilirubins are eluted and analyzed by the gradient of a phosphate buffer solution and isopropanol, using a reversed phase HPLC column (Journal of Chromatography, Volume 226, p 391, 1981) and the like. The method using an oxidizing enzyme is a method wherein the bilirubins are oxidized by an oxidizing enzyme to eliminate the absorption of around 450 nm of the bilirubins, whereby an amount of the bilirubins is calculated from the absorption change between before and after the reaction. In this method, the specificity of the oxidation of the bilirubins can be varied by changing reaction conditions. Reagents for this method include a reagent which contains bilirubin oxidase (Clinical Chemistry, Volume 20, p 783, 1974); a reagent which contains another oxidizing agent, such as laccase, tyrosinase, ascorbic acid oxidase and the like (Japanese Kokai Publication (unexamined) 17999/1984); a reagent for a quantitative determination of all bilirubins, which employs a nonionic surfactant (e.g. cholic acid etc.) or an aromatic carboxylic acid as a reaction accelerator (Japanese Kokai Publication (unexamined) 249060/1984 etc.); and a reagent for a quantitative determination of conjugated bilirubins wherein bilirubin oxidase is only acted on conjugated bilirubins by controlling the pH, a buffer solution and a surfactant. Examples of the reagents for conjugated bilirubins are a reagent whereby bilirubin oxidase is used in a buffer solution of pH 9 to 11 (Japanese Kokai Publication (unexamined) 58999/1987), a reagent whereby bilirubin oxidase is used in a buffer solution of pH 5 to 6 which contains an anionic surfactant (Japanese Kokai Publication (unexamined) 152955/1985), a reagent whereby bilirubin oxidase is used in a buffer solution of pH 3.5 to 4.5 (Japanese Kokoku Publication (examined) 44000/1986) and the like. Also, Japanese Kokai Publication (unexamined) 154162/1985 discloses a reagent for unconjugated bilirubins whereby the ratio of bilirubin in a specimen and bilirubin oxidase is limited within a specified range in a buffer solution of pH 8.0 which contains an anionic surfactant. In the method using a diazo reagent, all bilirubins and conjugated bilirubins are separately determined whether a reaction accelerator of the diazotization reaction is contained in the reagent or not. The separation ability, however, is insufficient in the practical use and more insufficient for a specimen which does not contain albumin or which contains chemicals, such as salicylic acid. It is also a problem in this method that, since the azobilirubins produced by the diazotization of conjugated bilirubins or the unconjugated bilirubin respectively have different spectrochemical properties, inaccuracy occurs in the measured results. Further, ditaurobilirubin which is used as a standard material of conjugated bilirubins is different from conjugated bilirubins in reactivity and spectrochemical properties after diazotization. The method using HPLC has sufficient selectivity, but requires an expensive and unique apparatus. It also takes a long period of time to measure. And the number of specimens to be measured is limited, too. The method using another oxidizing enzyme has a problem in that no adequate standard material is present, the situation of which is similar to the method using a diazo reagent. Since ditaurobilirubin or unconjugated bilirubins are different from conjugated bilirubins in body fluids in spectrochemical properties (e.g. absorptivity coefficient, peak absorption wavelength etc.) or in reactivity with a reagent, inaccuracy may occur in measured results. Thus, errors are caused if bilirubins in body fluids are separately determined using one standard material. It is also proposed that a combination of ditaurobilirubin and unconjugated bilirubin is used as a standard material, but the combination ratio has to be selected according to body fluids, thus its preparation is difficult. The reagents for determining conjugated bilirubins are formulated with premising that proteins, such as albumin, are present in the specimen. It therefore is difficult to precisely measure a specimen which contains a high ratio of bilirubins which are free from proteins, such as the serum of a new born baby or a serum containing salicylic acid. Further, Japanese Patent Publication (examined) 44000/1986 discloses a reagent for the quantitative determination of conjugated bilirubin, the pH range of which, however, is disadvantageous for bilirubin oxidase in view of stability and activity. The method measuring the unconjugated bilirubin, as described in Japanese Kokai Publication (unexamined ) 154162/1985, is not suitable for a specimen which contains unconjugated bilirubin in an unknown concentration, because the amount of bilirubin oxidase should be controlled by the amount of the unconjugated bilirubin. Also, since the reagent used for this method is functioning not only on the unconjugated bilirubin but also on some conjugated bilirubins, the result of this method is inaccurate. EP-A-238 914 and WPIL no. 85-090153 disclose the determination of total bilirubin by converting delta bilirubin using subtilisin or lipase and/or protease and subsequent treatment with bilirubin oxidase. JP-A-59-74997 relates to the determination of total bilirubin by treating a specimen with peroxide, a surfactant, an aromatic carboxylic acid, a protease and a peroxidase. Tohuku J.Exp.Med., Vol 147, p. 281-293 (1985) discloses that β-glucoronidase acts upon bile acides and can be followed by qualitative TLC analysis of the various bilirubins using an azo dye. Clin. Biochem. 20, p. 451-458 (1987) teaches a method for determining all types of bilirubin by oxidation. The present invention provides a process for measuring the amount of all bilirubins in a specimen, comprising deconjugating conjugated bilirubins with a reagent comprising an enzyme capable of deconjugation to form the unconjugated bilirubin, and determining the amount of the unconjugated bilirubin in the specimen. The present invention also provides a reagent for measuring the amount of all bilirubins comprising an enzyme capable of deconjugation employed at a concentration of 0.01-100 units/ml, and an oxidizing agent capable of oxidizing bilirubins or a diazotating component. Measurement of all bilirubins The reagent for measuring the amount of all bilirubins of the present invention is constituted of two agents. The first agent mainly contains an enzyme capable of deconjugating conjugated bilirubins to form unconjugated bilirugin and the second agent mainly contains an oxidizing agent to measure an amount of the unconjugated bilirubin. The enzyme of the first agent includes a sugar ester hydrolase, such as glucuronidase, glucosidase, galactosidase etc,; sulfatase; or mixtures thereof. In case where the specimen is a body fluid of man, glucoronidase which is not combined with the other enzymes is preferred. The The enzyme may be derived from any animal , plant or microorganism , for example, glucuronidase which is derived from bovine liver, from snails or Escherichia coli; glucosidase which is derived from yeast or almond ; galactosidase which is derived from Escherichia coli, and sulfatase which is derived from snails. The enzyme can be employed in a concentration of 0.01 to 100 units/ml, preferably 0.05 to 50 units/ml. Concentrations of less than 0.01 units/ml take a long time to complete deconjugating reactions. Concentrations of more than 100 units/ml make the reagent expensive and delay the deconjugating reactions due to a high protein concentration. Also, conjugated bilirubins may be oxidized with impurities contained in the enzyme. The oxidizing agent capable of oxidizing the bilirubins includes an enzyme capable of oxidizing bilirubins, such as bilirubin oxidase or laccase; a combination of an oxidase for producing hydrogen peroxide, such as glucose oxidase, peroxidase and a substrate thereof; a transition metal ion capable of oxidizing the bilirubins, or a salt thereof, such as copper sulfate, copper chloride, ferric sulfate and the like; and a peroxide, such as potassium persulfate, sodium perbenzoate and the like. The diazo reagent of the second agent includes a hydrochloric acid solution containing sulfanilic acid and and nitrous acid, a mixture of 2,4-dichloroaniline and sulfanilic acid and the like; or a combination thereof. A concentration of the oxidizing agent is 0.01 to 30 units/ml, preferably 0.05 to 10 units/ml for the enzyme for oxidizing bilirubins; 0.01 to 50 mM, preferably 0.05 to 30 mM for the peroxide; 0.01 to 20 mM, preferably 0.05 to 5 mM for the transition metal ion or a salt thereof: 0.05 to 5 mM, preferably 0.1 to 2 mM for the diazo reagent. If the concentration is outside the above range, it takes a long time to complete the oxidizing reactions of the unconjugated bilirubin or the deterioration of the reagent is significant. The possiblity that precipitates one produced also exist. The oxidizing enzyme may be derived from anything. For example, laccase can be derived from lacquer trees or microorganisms (e.g. genus Polyporus), bilirubin oxidase can be derived from microorganism (e.g. genus Myrothecium or genus Trachyderma) or glucose oxidase can be derived from microorganisms (e.g. genus Aspergillus, etc.). In addition to the above mentioned components, the first or second reagent may further contain a reaction promoter (e.g. an aromatic carboxylic acid), a surfactant, a buffer, a chelating agent, activating agents or salts. Examples of the aromatic carboxylic acids are p-toluenesulfonic acid, benzoic acid and the like. The aromatic carboxylic acid may be present in the reagent in a concentration of 5 to 7 mM, preferably 10 to 50 mM. If the concentration is outside the above range, it takes a long time to complete reactions or precipitates may occur. The surfactant may be anionic, nonionic, cationic or ampholytic, for example sodium dodecylsulfate, cholic acid, polyoxyethylene glycol, Triton® X-100 (available from Nakarai Chemical Co., Ltd.), Tween® 80 (available from Wako Pure Chemical Industries), lauryl pyridinium chloride, lauryl trimethylammonium chloride, N-lauryl myristyl-beta-aminopropionic acid, N-lauryl-beta-imino-dipropionic acid and the like. The surfactant may be present in the reagent in a concentration of 0.01 to 10 % by weight, preferably 0.05 to 2 % by weight. Concentrations of more than 10 % by weight may produce precipitates and reduce flowability thereby making it difficult to apply an automatic analyzer. The buffer solution for the first reagent is preferably one which has a pH range near an optimum pH range of the enzyme capable of deconjugation, and the buffer solution for the second reagent is preferably one which has pH range near an optimum pH range of the oxidizing agent. Examples of the buffer solutions for the first reagent are a phthalic acid-sodium hydroxide buffer (pH 5), a succinic buffer (pH 5) acid-sodium hydroxide buffer (pH 5) and the like, if it employs beta-glucoronidase derived from bovine liver. Examples of the buffer solutions for the second reagent are a phosphoric acid buffer (pH 7.0), a HEPES buffer (pH 7.0) and the like, if the oxidizing agent is bilirubin oxidase. The buffer solution may be used in a concentration of 20 to 500 mM, preferably 30 to 200 mM. If it is less than 20 mM, a pH value of the reagent may change when a specimen is added to the reagent. If it is more than 500 mM, it takes a long time to react and precipitation may occur in the reagent. The chelating agent includes a polyaminocarboxylic acid such as ethylenediaminetetraacetic acid (EDTA), or an oxycarboxylic acid such as citric acid. The chelating agent can be present in the reagent in a concentration of 0.01 to 100 mM, preferably 0.05 to 50 mM. The fillers include polyethylene glycol, albumin, sugars and the like. Polyethylene glycol may be employed in a concentration of 0.01 to 20 %, preferably 0.05 to 2 %, albumin may be 0.01 to 50 mM, preferably 0.05 to 10 mM and sugars may be 1 to 100 mM, preferably 5 to 50 mM. Salts include sodium chloride, ammonium chloride, potassium sulfate and the like. They may be employed in a concentration of 1 to 500 mM, preferably 5 to 100 mM. The reagent for measuring the amount of all bilirubins of the present invention generally contains unconjugated bilirubin as a standard material in a known concentration within 0.1 to 80 mg/dl, preferably 0.5 to 60 mg/dl. The unconjugated bilirubin might be that which is available from Daiichi Kagaku Yakuhin Co., Ltd. or Shigma Chemical Co., Ltd., or which is obtained from gallbladder of pigs, horses and men. The unconjugated bilirubin is used intact or in a combination with a stabilizing agent (e.g. polyethylene glycol, albumin, sugars, chelating agents, salts) or a filler. The amount of polyethylene glycol is within the range of 0.01 % to 30 % by weight, the amount of albumin is 0.01 to 50 mM, sugars are 1 to 300 mM, chelating agents are 0.01 to 100 mM and salts are 1 to 500 mM. A high bilirubin control standard serum which is commercially available can be employed, but it is desirable that the standard serum only contains the unconjugated bilirubin in a precise amount. The first and second reagents and the standard material can take any forms, such as solution, freezed and dried, as long as they are solutions upon using. The above forms can be prepared by methods known in the art. According to the present invention, a preferred composition is described here. The first reagent contains beta-glucuronidase derived from bovine liver in a concentration of 0.05 to 10 units/ml, p-toluenesulfonic acid in a concentration of 5 to 75 mM, EDTA in a concentration of 0.01 to 20 mM and a succinic acid-sodium hydroxide buffer of pH 4 to 6 in a concentration of 20 to 500 mM. The second reagent contains bilirubin oxidase in a concentration of 0.05 to 10 units/ml, p-toluenesulfonic acid in a concentration of 10 to 50 mM, EDTA in a concentration of 0.05 to 50 mM and a phosphoric acid buffer of pH 5 to 8 in a concentration of 20 to 500 mM. The process for measuring a total amount of bilirubins may be carried out by converting conjugated bilirubins in a specimen with a reagent containing the enzyme capable of deconjugation into the unconjugated bilirubin and directly determining by HPLC or determining the change in absorbance when the unconjugated bilirubins are treated with the oxidizing agent or diazo reagent to oxidized or azotized unconjugated bilirubins, respectively. In the above mentioned process, since the conjugated bilirubins in the specimen are all converted into the unconjugated bilirubin, only the unconjugated bilirubin can be used as standard material. In the process for measuring the total amount of bilirubins, 0.6 ml of the first reagent is pre-heated in a cell chamber in a spectrometer, to which a specimen of a suitable amount (e.g. serum) which contains various bilirubins is added and reacted for 1 to 10 minutes to convert all conjugated bilirubins to the unconjugated bilirubin, whereby an absorbance change at 460 nm is measured. Next, 0.15 ml of the second reagent is added thereto and reacted for 1 to 10 minutes to oxidize all the unconjugated bilirubin, whereby an absorbance at 460 nm is measured. An absorbance change (A) is then calculated from the latter absorbance and the former absorbance which is corrected in terms of a volume fraction. Separately, a standard material which contains the unconjugated bilirubin of a known concentration is measured as mentioned above to obtain an absorbance change (B). A total bilirubin content is calculated from the following formula; Total content (mg/dl) of bilirubins in the specimen = A B X Content (mg/dl) of the non-conjugated bilirubin in the standard material A temperature for pre-heating and reactions is preferably 25 to 37 °C and an amount of the specimen is preferably 0.005 to 0.1 ml. A wavelength for determination may be selected within the range of 400 to 480 nm. Amounts of the first and second reagents and the specimen may be varied. If the specimen only contains conjugated bilirubins, the absorbance change corresponds to not only the amount of the conjugated bilirubins but also the amount of the all bilirubins in the specimen. In case where the second reagent contains a diazo reagent, the determination can be carried out by producing azo dyes in place of oxidizing bilirubins. It is also possible that, after reacting the first reagent with the specimen, conjugated bilirubins produced are directly subjected to a quantitative analysis by using HPLC. Fig.1 is an HPLC analysis pattern of Example 1. Fig.3 is an HPLC analysis pattern which is conducted in Example 7. EXAMPLES The present invention is illustrated by the following Examples which, however, are not to be construed as limiting the invention to their details. Reference Example 1 Glucuronide bilirubins, one of conjugated bilirubins, were purified from pig bile as described in Bunseki Kagaku, Volume 31, E 63 page, 1982. Glucuronide bilirubins and the unconjugated bilirubin were analyzed by modifying the Lauff et al. method (Journal of Chromatography, Volume 226 , p 391, 1981. The analysis was carried out using a Lichrosorb® RP-8 (particle size of 10 micrometer) chromatographic column with a gradient elution of a phosphoric acid buffer solution (pH 2.0) containing 5 % methyl cellosolve and acetonitrile. Example 1 A reagent for measuring the amount of all bilirubins was prepared as follows. The first reagent was prepared from beta-glucuronidase (available from Shigma Chemical Co., Ltd. as G0251) of 0.2 units/ml, p-toluenesulfonic acid of 30 mM, EDTA of 1mM, Triton® X-100 of 0.03 % by weight and a phthalic acid buffer solution (pH 5.0) of 100 mM. The second reagent was prepared from bilirubin oxidase (available from Shigma Chemical Co., Ltd. as B1515) of 4 units/ml, p-toluenesulfonic acid 30 mM, EDTA of 1 mM, Triton® X-100 of 0.03 % by weight and a phosphoric acid buffer solution of 200 mM. The second reagent was adjusted to pH 10.0. The first reagent of 1 ml was pre-heated to 37 °C for 2 minutes, to which 0.05 ml of glucuronide bilirubin obtained in Reference Example 1 was added and reacted for 3 minutes at 37 °C. At 37 °C, 0.25 ml of the second reagent was added and reacted for 3 minutes. The reaction mixture (a) after adding the first reagent and the reaction mixture (b) after adding the second reagent were analyzed by HPLC and the result is shown in Fig.1. A reaction mixture (c) was obtained by reacting the glucuronide bilirubin sample with the first reagent which excluded beta-glucuronidase and analyzed by HPLC. The result is also shown in Fig.1. In Fig.1, a peak which was eluted at about 11 minutes is glucuronide bilirubins, and a peak at about 18 minutes is the unconjugated bilirubin. The line (c) in Fig.1 shows conditions of the sample before reacting with beta-glucuronidase which is a deconjugating enzyme. In Fig.1, it is clear from comparing (a) with (c) that glucuronide bilirubins were completely converted into the unconjugated bilirubin. It is also clear from comparing (b) with (c) that the unconjugated bilirubin was all oxidized and eliminated by the second reagent. Example 2 Some diluted solutions which contain glucuronide bilirubins purified in Reference Example 1 in various concentration were prepared and a relationship between a glucuronide bilirubin content and absorbance change was examined using the reagent for measuring an amount of all bilirubins prepared in Example 1. The first reagent of 1 ml was pre-heated to 37 °C for 2 minutes, to which 0.05 ml of glucuronide bilirubin solutions having various concentrations was added and reacted for 3 minutes at 37 °C and an absorbance at 460 nm was measured. At 37 °C, 0.25 ml of the second reagent was added and reacted for 5 minutes and an absorbance at 460 nm was measured. A linear relationship was obtained between the dilution ratio of sample and the absorbance change. Example 3 This example shows effects of additives in a sample on the measurement. The additives, i.e. human albumin (available from Shigma Chemical Co., Ltd. as A 3782), salicylic acid, EDTA and hemoglobin, were respectively added to the glucuronide bilirubin solution purified in Reference Example 1 in an amount shown in Table 1 and a quantitative determination was carried out as generally described in Example 2. The results are described in Table 1. The unconjugated bilirubin of 5 mg/dl in 100 mM Tris-hydrochloric acid buffer (pH 8.0) was used as a standard material. Additive (mg/dl) Measured value of all bilirubins (mg/dl) Nothing 10.5 Human albumin 2 10.5 5 10.5 10 10.4 Salicylic acid 5 10.5 10 10.6 EDTA 50 10.5 500 10.6 Hemoglobin 300 10.6 600 10.5 As apparent from Table 1, the determination of all bilirubins is not affected at all by the additives. In conventional methods, the effects of such chemical materials present in a sample are very troublesome on the measured value of bilirubins, but the present invention has no such problems. Example 4 A sample which contained glucuronide bilirubins purified in Reference Example 1 and the unconjugated bilirubin was prepared. The reaction mixture (a) after adding the first reagent and the reaction mixture (b) after adding the second reagent were analyzed by HPLC and the result is shown in Fig.3. A reaction mixture (c) was obtained by reacting the glucuronide bilirubin sample with the first reagent which excluded bilirubin oxidase and copper sulfate and analyzed by HPLC. The result is also shown in Fig.3. In Fig.3, a peak which was eluted at about 11 minutes is glucuronide bilirubins, and a peak at about 18 minutes is the unconjugated bilirubin. Fig.3 shows that the first reagent for measuring the unconjugated bilirubins can oxidize and eliminate only the conjugated bilirubins and the remaining unconjugated bilirubin can be quantitatively determined by the addition of the second reagent. Example 5 A standard material A which contained 10 mg/dl of the unconjugated bilirubin, 10 mg/dl of ditaurobilirubin and 26.8 g/l of human albumin was prepared. A sample A was also prepared by mixing 10 ml of a 10 mg/dl unconjugated bilirubin with 1 ml of glucuronide bilirubin sample of Reference Example 1. The standard material was reacted with the reagent for all bilirubins of Example 1 and the resultant absorbance change was measured. Separately, the sample A was reacted with the reagent for all bilirubins and an absorbance change was measured. An amount of conjugated bilirubins, unconjugated bilirubin and all bilirubins in the sample A was obtained from the absorbance changes and the results are shown in Table 3. Comparative Example The sample A and standard material A of Example 5 were analyzed by the HPLC method of Reference Example 1. An amount of the unconjugated bilirubin in the sample A was calculated from a proportion of a peak area of the unconjugated bilirubin in the sample A and a peak area of the unconjugated bilirubin in the standard material A. Also, an amount of conjugated bilirubins in the sample A was calculated from the proportion of a peak area of the glucuronide bilirubins in the sample A and a peak area of ditaurobilirubin of the standard material A. The results are shown in Table 2. Analysis method Measured value (mg/dl) All bilirubins Conjugated one Unconjugate one Present invention 12.6 7.45 5.15 HPLC 12.66 7.52 5.15 In the Comparative Example 4, the amount of all bilirubins and the conjugated bilirubins is converted into theamount of the unconjugated bilirubin, provided that glucuronide bilirubins is considered to diglucuronide bilirubin and then calculated from the molecular weight of ditaurobilirubin and the molecular weight of the unconjugated bilirubin. It has been found from Table 2 that the results for the reagents of the present invention are very close to those from the HPLC method. Especially, the amount of the unconjugated bilirubin is identical in both methods and it is therefore found that the reagents of the present invention has superior in fractionating abilities. According to the present invention, a quantitative determination of various bilirubins can be carried out precisely by a simple process without the influence by the presence of albumin and other chemicals in a specimen. In the present invention, the unconjugated bilirubin which can be easily available is used as a sole standard material and therefore solve the problems of conventional methods, such as inaccuracy and the like. Also, since the present invention uses an enzyme in good conditions for the enzymatic reaction, the performance of the reagent is enhanced. The reagents and methods of the present invention have many advantages, particularly in clinical examinations.

Claims: A process for measuring the total amount of all bilirubins in a specimen, comprising; deconjugating conjugated bilirubins with a reagent comprising an enzyme capable of deconjugation to form unconjugated bilirubin, and determining the amount of unconjugated bilirubin in the specimen. The process according to Claim 1 wherein the amount of unconjugated bilirubin is directly determined by a HPLC method. The process according to Claim 1 wherein the amount of unconjugated bilirubin is determined from an absorbance change resulting from the treatment of the unconjugated bilirubin with an oxidizing reagent or a diazo reagent. A reagent for measuring the amount of all bilirubins comprising; an enzyme capable of deconjugation employed at a concentration of 0.01-100 units/ml, and an oxidizing agent capable of oxidizing bilirubins or a diazo component. The reagent according to Claim 4 being constituted as a combined preparation of two compositions for separate sequential use in measuring the amount of all bilirubins of which the first composition comprises the enzyme capable of deconjugation and the second composition comprises the oxidizing agent capable of oxidizing bilirubins or the diazo component. The reagent according to Claim 4 wherein said enzyme capable of deconjugation is sugar ester hydrolase, sulfatase or a mixture thereof. The reagent according to Claim 4 wherein said oxidizing agent capable of oxidizing bilirubins is an enzyme, an oxidase which produces hydrogen peroxide, a transition metal ion or a peroxide. The reagent according to Claim 4 wherein said oxidizing agent capable of oxidizing bilirubins is bilirubin oxidase, laccase, glucose oxidase, copper sulfate, copper peroxide, ferric sulfate, potassium persulfate or sodium perbenzoate. The reagent according to Claim 4 wherein said diazo component is a hydrochloric acid mixture of sulfanilic acid and nitrous acid, or a mixture of 2,4-dichloroaniline and sulfanilic acid. The reagent according to Claim 7 wherein said oxidizing agent is present in the reagent in a concentration of 0.01 to 30 units/ml for the enzyme, 0.01 to 50 mM for the peroxide, and 0.01 to 5 mM for the transition metal ion. The reagent according to Claim 4 wherein said diazo component is present in the reagent in a concentration of 0.05 to 5 mM. The reagent according to Claim 4 further comprising a reaction promoter, a surfactant, a buffer, a chelating agent, fillers and salts. The reagent according to Claim 5 wherein said first composition comprises beta-glucuronidase derived from bovine liver in a concentration of 0.05 to 10 units/ml, p-toluenesulfonic acid in a concentration of 5 to 75 mM, ethylenediaminetetraacetic acid in a concentration of 0.01 to 20 mM and a succinic acid-sodium hydroxide buffer of pH 4 to 6 in a concentration of 20 to 500 mM, and said second composition contains bilirubin oxidase in a concentration of 0.05 to 10 units/ml, p-toluenesulfonic acid in a concentration of 10 to 50 mM, ethylenediaminetetraacetic acid in a concentration of 0.05 to 50 mM and a phosphoric acid buffer solution of pH 5 to 8 in a concentration of 20 to 500 mM.

Inventors: KONDO HITOSHI, MATSUI KAZUHIRO, SUZUKI HIROSHI, KONDO, HITOSHI, MATSUI, KAZUHIRO, SUZUKI, HIROSHI, KONDO, HITOSHI, C/O CENTRAL LABORATORY UNITIKA LTD, SUZUKI, HIROSHI, C/O YACHIYO FACTORY
Applicants: IATRON LAB, UNITIKA LTD, IATRON LABORATORIES, INC., UNITIKA LTD.
Application year: 1990
Main classification: G01N33
IPC codes: C12Q1, G01N33